Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-27
DOI
10.1038/s41467-017-02251-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Encapsulation of a nitric oxide donor into a liposome to boost the enhanced permeation and retention (EPR) effect
- (2017) Yu Tahara et al. MedChemComm
- NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models
- (2016) D. H. Charych et al. CLINICAL CANCER RESEARCH
- Immunocytokines for cancer treatment: past, present and future
- (2016) Dario Neri et al. CURRENT OPINION IN IMMUNOLOGY
- Rationale for anti-CD137 cancer immunotherapy
- (2016) Amani Makkouk et al. EUROPEAN JOURNAL OF CANCER
- Super enhanced permeability and retention (SUPR) effects in tumors following near infrared photoimmunotherapy
- (2016) Hisataka Kobayashi et al. Nanoscale
- Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
- (2016) Kelly D Moynihan et al. NATURE MEDICINE
- Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice
- (2016) Stefanie N. Linch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2
- (2015) Eric F. Zhu et al. CANCER CELL
- Integration of imaging into clinical practice to assess the delivery and performance of macromolecular and nanotechnology-based oncology therapies
- (2015) Tara Spence et al. JOURNAL OF CONTROLLED RELEASE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution
- (2015) Alice Tzeng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle
- (2015) Miles A. Miller et al. Science Translational Medicine
- Immunotherapy Combinations With Checkpoint Inhibitors in Metastatic Melanoma: Current Approaches and Future Directions
- (2015) Michael Atkins SEMINARS IN ONCOLOGY
- Combined Stimulation of IL-2 and 4-1BB Receptors Augments the Antitumor Activity of E7 DNA Vaccines by Increasing Ag-Specific CTL Responses
- (2014) Ha Kim et al. PLoS One
- Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
- (2013) B. Kwong et al. CANCER RESEARCH
- Agonistic CD40 Antibodies and Cancer Therapy
- (2013) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- Review of Long-Wavelength Optical and NIR Imaging Materials: Contrast Agents, Fluorophores, and Multifunctional Nano Carriers
- (2012) Vikram J. Pansare et al. CHEMISTRY OF MATERIALS
- In Vivo Gene Delivery by Nonviral Vectors: Overcoming Hurdles?
- (2012) Yuan Zhang et al. MOLECULAR THERAPY
- Odyssey of a cancer nanoparticle: From injection site to site of action
- (2012) Joseph W. Nichols et al. Nano Today
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
- (2012) Aron M. Levin et al. NATURE
- Transcriptional control of natural killer cell differentiation and function
- (2011) Alfonso Martín-Fontecha et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodies
- (2011) A. J. Christiansen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Liposomal cancer therapy: exploiting tumor characteristics
- (2010) Thomas Kaasgaard et al. Expert Opinion on Drug Delivery
- Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells
- (2010) C. Krieg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- [186Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model
- (2009) Anuradha Soundararajan et al. NUCLEAR MEDICINE AND BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now